- Home
- LPL vs CPRX Comparison
LPL vs CPRX Comparison
Compare LPL & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPL
- CPRX
- Stock Information
- Founded
- LPL 1985
- CPRX 2002
- Country
- LPL South Korea
- CPRX United States
- Employees
- LPL N/A
- CPRX N/A
- Industry
- LPL Industrial Machinery/Components
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- LPL Technology
- CPRX Health Care
- Exchange
- LPL Nasdaq
- CPRX Nasdaq
- Market Cap
- LPL 3.4B
- CPRX 2.9B
- IPO Year
- LPL 2004
- CPRX 2006
- Fundamental
- Price
- LPL $3.40
- CPRX $21.81
- Analyst Decision
- LPL Sell
- CPRX Strong Buy
- Analyst Count
- LPL 2
- CPRX 6
- Target Price
- LPL N/A
- CPRX $32.83
- AVG Volume (30 Days)
- LPL 225.9K
- CPRX 1.4M
- Earning Date
- LPL 07-24-2025
- CPRX 08-06-2025
- Dividend Yield
- LPL N/A
- CPRX N/A
- EPS Growth
- LPL N/A
- CPRX 178.13
- EPS
- LPL N/A
- CPRX 1.57
- Revenue
- LPL $18,624,457,609.00
- CPRX $534,645,999.00
- Revenue This Year
- LPL N/A
- CPRX $16.37
- Revenue Next Year
- LPL N/A
- CPRX $8.80
- P/E Ratio
- LPL N/A
- CPRX $13.91
- Revenue Growth
- LPL 23.70
- CPRX 29.97
- 52 Week Low
- LPL $2.43
- CPRX $15.34
- 52 Week High
- LPL $4.86
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- LPL 50.93
- CPRX 42.36
- Support Level
- LPL $3.30
- CPRX $20.62
- Resistance Level
- LPL $3.45
- CPRX $22.06
- Average True Range (ATR)
- LPL 0.09
- CPRX 0.66
- MACD
- LPL -0.02
- CPRX 0.03
- Stochastic Oscillator
- LPL 27.14
- CPRX 56.67
About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES
LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).